Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 7.14 percent. This is a 87.5 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $67.70 million which beat the analyst consensus estimate of $64.00 million by 5.78 percent. This is a 11.11 percent increase over sales of $60.93 million the same period last year.